[New anticancer molecules: drugs for tomorrow?].
Lavelle
F
F
Rhône-Poulenc Rorer, Centre de recherche de Vitry-Alfortville, 94403 Vitry-sur-Seine Cedex.
D019883:Alkyl and Aryl Transferases / Q000037:antagonists & inhibitors*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D051231:Farnesyltranstransferase; D005544:Forecasting; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use; D003986:Dibenzocycloheptenes
D019883:Alkyl and Aryl Transferases; D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D051231:Farnesyltranstransferase; D016376:Oligonucleotides, Antisense; D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011725:Pyridines; C115354:lonafarnib; D003986:Dibenzocycloheptenes